Nephron recalls Rocuronium Bromide Injection (50 mg/5mL) due to lack of sterility assurance. This could lead to infections if used improperly. Affected products have specific NDC and lot numbers.
Lack of Assurance of Sterility
Nephron is recalling Rocuronium Bromide Injection syringes because they may not be sterile. Using these could cause infections, especially in medical settings where sterility is critical.
The injection may not be sterile, which can lead to infections if used in medical procedures. This is a serious risk for patients receiving the medication.
Healthcare professionals and patients using this medication under prescription. Those with the specific NDC and lot numbers are most at risk.
Check for NDC 69374-924-05 and lot number RC2003B on the packaging. Products were sold with a specific expiration date of August 28, 2022.
Look for NDC 69374-924-05 and lot number RC2003B on the packaging.
The recall states there is a lack of sterility assurance, so it is not safe to use. The product should be discarded.
Check the packaging for NDC 69374-924-05 and lot number RC2003B. If you have these details, contact Nephron for instructions.
The product was manufactured with a lot number RC2003B and expires on August 28, 2022.
We’ve drafted a message you can send Nephron to request your refund or repair — edit it as you like.
Subject: Recall D-1277-2022 — Nephron Nephron Hello, I own a Nephron that is covered by recall D-1277-2022 from Nephron. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
